Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data

Deanna Kepka, Michael G Spigarelli, Echo L Warner, Yukiko Yoneoka, Nancy McConnell, Alfred Balch, Deanna Kepka, Michael G Spigarelli, Echo L Warner, Yukiko Yoneoka, Nancy McConnell, Alfred Balch

Abstract

Background: Human papillomavirus (HPV) vaccine 3-dose completion rates among adolescent females in the US are low. Missed opportunities impede HPV vaccination coverage.

Methods: A population-based secondary data analysis of de-identified vaccination and demographic data from the Utah Statewide Immunization Information System (USIIS) was conducted. Records were included from 25,866 females ages 11-26 years at any time during 2008-2012 who received at least one of the following adolescent vaccinations documented in the USIIS: Tdap (Tetanus, Diphtheria, Pertussis), meningococcal, and/or influenza. A missed opportunity for HPV vaccination was defined as a clinical encounter where the patient received at least one adolescent vaccination, but not a HPV vaccine.

Results: Of 47,665 eligible visits, there were 20,911 missed opportunities (43.87%). Age group, race/ethnicity, and rurality were significantly associated with missed opportunity (p<0.0001). In a multivariable mixed-effects logistic regression model that included ethnicity, location and age, as fixed effects and subject as a random effect, Hispanics were less likely to have a missed opportunity than whites OR 0.59 (95% CI: 0.52-0.66), small rural more likely to have a missed opportunity than urban youth OR 1.8 (95% CI: 1.5-2.2), and preteens more likely than teens OR 2.4 (95% CI: 2.2-2.7).

Conclusion: Missed clinical opportunities are a significant barrier to HPV vaccination among female adolescents. Interventions targeted at providers who serve patient groups with the highest missed opportunities are needed to achieve adequate protection from HPV-associated illnesses.

Impact: This is one of the first studies to utilize state immunization information system data to assess missed opportunities for HPV vaccination.

Keywords: HPV vaccine; adolescent; demographic factors; preventive medicine; registries.

Conflict of interest statement

Disclosures: None reported.

References

    1. L.E. Markowitz, E.F. Dunne, M. Saraiya, H.W. Chesson, C.R. Curtis, J. Gee, et al., Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep., vol. 63(Rr-05), 2014, pp. 1–30. Epub 2014/08/29. PubMed PMID: 25167164.
    1. S. Reagan-Steiner, D. Yankey, J. Jeyarajah, L.D. Elam-Evans, J.A. Singleton, R. Curtis, et al., National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2014. MMWR Morb Mortal Wkly Report, vol. 64(29), 2015, pp. 784–792.
    1. B.K. Rimer, H. Harper, O.N. Witte, Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. A Report to the President of the United States from the President's Cancer Panel. Bethesda, MD, 2014.
    1. Healthy People 2020 Topics & Objectives: United States Department of Health and Human Services. Available from: 〈〉, 2010.
    1. Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013—United States. MMWR, vol. 62(29), 2013, pp. 591–595.
    1. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013 – United States. MMWR Morb Mortal Wkly Rep., vol. 62(29), 2013, pp. 591–595. Epub 2013/07/26. PubMed PMID: 23884346.
    1. Vadaparampil S.T., Kahn J.A., Salmon D., Lee J.H., Quinn G.P., Roetzheim R. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine. 2011;29(47):8634–8641. PubMed PMID: 21924315; PubMed Central PMCID: PMCPmc3200426.
    1. R.U.C.A. Using Data: WWAMI Rural Health Research Center; 2015 [cited 2015 03/31]. Available from: , 2015.
    1. Holman D.M., Benard V., Roland K.B., Watson M., Liddon N., Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pedia. 2014;168(1):76–82. 10.1001/jamapediatrics.2013.2752. PubMed PMID: 24276343.
    1. Kessels S.J., Marshall H.S., Watson M., Braunack-Mayer A.J., Reuzel R., Tooher R.L. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–3556. PubMed PMID: 22480928.
    1. Centers for Disease Control and Prevention. Vaccines for Children Program (VFC), VFC Eligibility Criteria [9/8/2015]. Available from: , 2015.
    1. Zimet G.D., Weiss T.W., Rosenthal S.L., Good M.B., Vichnin M.D. Reasons for non-vaccination against HPV and future vaccination intentions among 19-2 year-old women. BMC Womens Health. 2010;10:27. PubMed PMID: 20809965; PubMed Central PMCID: PMCPmc2941477.
    1. Licht A.S., Murphy J.M., Hyland A.J., Fix B.V., Hawk L.W., Mahoney M.C. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception. Sex. Transm. Infect. 2010;86(1):74–78. PubMed PMID: 19841004.
    1. Mormons by State: Pew Research Center, [cited 16.07.15]. Available from: , 2015.
    1. Constantine N.A., Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J. Adolesc. Health. 2007;40(2):108–115. PubMed PMID: 17259050.
    1. Jeudin P., Liveright E., Del Carmen M.G., Perkins R.B. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Clin. Ther. 2014;36(1):24–37. PubMed PMID: 24417783.
    1. State and Salt Lake: County QuickFacts City, Utah 2014 [cited 21.08.14]. Available from: , 2014.
    1. Leung J., McKenzie S., Martin J., McLaughlin D. Effect of rurality on screening for breast cancer: a systematic review and meta-analysis comparing mammography. Rural Remote Health. 2014;14(2):2730. Epub 2014/06/24. PubMed PMID: 24953122.
    1. Butow P.N., Phillips F., Schweder J., White K., Underhill C., Goldstein D. Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer. 2012;20(1):1–22. PubMed PMID: 21956760.
    1. Obertova Z., Brown C., Holmes M., Lawrenson R. Prostate cancer incidence and mortality in rural men--a systematic review of the literature. Rural Remote Health. 2012;12(2):2039. Epub 2012/05/24. PubMed PMID: 22616627.
    1. Belasco E.J., Gong G., Pence B., Wilkes E. The impact of rural health care accessibility on cancer-related behaviors and outcomes. Appl Health Econ. Health Policy. 2014;12(4):461–470. PubMed PMID: 24889860.
    1. Keating K.M., Brewer N.T., Gottlieb S.L., Liddon N., Ludema C., Smith J.S. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J. Adolesc. Health. 2008;43(Suppl. 4):S61–S67. PubMed PMID: 18809147.
    1. K. Stewart, Utah Health Official Bans Gardasil, stirring Controversy Salt Lake Tribune, 2013.
    1. 2014 IISAR Data Participation Rates, Centers for Disease Control and Prevention. [cited 22.02.16] Available from: 〈〉, 2016.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe